Clinical trial
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
NCT03000257
Study timeline
Study start (actual)2016-12-14Date precision: day
Registry last updated2022-04-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Solid Tumorsunresolved
Interventions
Sponsors & collaborators
AbbVielead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03000257 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.